South African coronavirus variant found in the Netherlands The South African variant of the coronavirus (501Y.V2) has been identified in the Netherlands for the first time.
Update on the spread of the UK coronavirus variant (VOC 202012/01) in the Netherlands The number of people that have been found to have the new SARS-CoV-2 coronavirus variant designated VOC 202012/01 (the UK variant) has risen from 11 to nearly 50 individuals.
First COVID-19 vaccination in the Netherlands given at GGD vaccination site in Veghel Care workers in nursing homes and small-scale residential facilities received the first COVID-19 vaccinations in the Netherlands this morning at the GGD vaccination location ‘Hart voor Brabant’ in
Decisive decrease not yet visible Decisive effects from the lockdown of 15 December have yet to be seen. Although there was a decrease in the number of people who were tested and the number of people who tested positive for COVID-19.
Care workers in nursing homes and small-scale residential facilities invited for COVID-19 vaccination starting today As of today, the ca. 269,000 care workers of nursing homes and small-scale residential facilities in the Netherlands are invited to make an appointment for a COVID-19 vaccination.
Higher mortality during heatwave in July in the Netherlands During the last heatwave, almost 400 more deaths were reported than was expected on overage for that period. The additional deaths mainly concerned persons aged 75 years and older.
Number of STIs continues to rise at Dutch STI clinics In the first half of this year more STIs were found in people who have been tested at Dutch STI clinics. The increase pertains to all STIs, with the exception of HIV.
European Antibiotic Awareness Day 2016 Friday 18 November is European Antibiotic Awareness Day. On this day, throughout Europe attention focuses on the threat of antibiotic resistance to people and animals.
EU legislation genetically modified microbial biocontrol agents is fit for purpose EU legislative instruments are sufficient to ensure the safety of such products.
Surveillance and developments National Immunisation Programme 2015-2016 The report provides an overview of effectiveness and safety of vaccines and vaccine research.